Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We are a biopharmaceutical company focused on the discovery and development of novel therapeutics to treat metabolic diseases including nonalcoholic steatohepatitis (NASH).Suggesting new paradigms of metabolic disease treatment, Glaceum is developing integrated therapies to meet the needs of those living with obesity, liver disease, and type 2 diabetes. We are committed to a universal treatment for patients with metabolic dis...
We are a biopharmaceutical company focused on the discovery and development of novel therapeutics to treat metabolic diseases including nonalcoholic steatohepatitis (NASH).Suggesting new paradigms of metabolic disease treatment, Glaceum is developing integrated therapies to meet the needs of those living with obesity, liver disease, and type 2 diabetes. We are committed to a universal treatment for patients with metabolic disease by restoring their homeostatic balance.

List your booth number for exhibitions, ask us